Guo, J., Li, Q., Zhang, P., Yuan, P., Wang, J., Ma, F., . . . Xu, B. (2019). Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients. Chin J Cancer Res.
Chicago Style CitationGuo, Jihong, et al. "Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2 (HER2)-positive Early-stage Breast Cancer: A Real-world Retrospective Study in Chinese Patients." Chin J Cancer Res 2019.
Cita MLAGuo, Jihong, et al. "Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2 (HER2)-positive Early-stage Breast Cancer: A Real-world Retrospective Study in Chinese Patients." Chin J Cancer Res 2019.